Literature DB >> 35190952

Exploration of a Brain-Liver-Communication-Related Mechanism Involved in the Experimental Perimenopausal Depression Rat Model using Chaihu-Shugan-San.

Qiliang Chen1,2, Candong Li2, Enxiang Tao3, Tetsuya Asakawa4,5, Yuanyuan Zhang6.   

Abstract

Existing research suggests the involvement of a brain-liver-communication-related mechanism in the occurrence of depression. In this study, we selected Chaihu-Shugan-San (CSS), a traditional Chinese herbal medicine that can simultaneously affect liver and depression, as a probe to investigate the involvement of the brain-liver-communication-related mechanism in perimenopausal depression. A total of 50 experimental perimenopausal depression rat models were established by ovariectomy surgery (PMS) followed by chronic unpredictable mild stress (CUMS) processes. Animals underwent CSS treatment or treatments with CSS + Ly294002, an inhibitor of the PI3K/Akt signalling pathway. We observed the behavioural performances of depression and anxiety, serum concentrations of biochemical indices, serum estrogen two levels, hippocampal 5-HT and NE levels and the morphological changes in liver tissues. The protein and mRNA expressions of PI3K and Akt were also evaluated. CSS treatment significantly ameliorated the behavioural performance, partial biochemical indices and the morphological changes in the liver tissues of PMS + CUMS rats. Ly294002 partially inhibited the CSS effects. The expressions of PI3K and Akt were significantly downregulated by PMS + CUMS processes but upregulated by CSS treatment, which could be significantly suppressed by Ly294002. A brain-liver-communication-related mechanism may be involved in perimenopausal depression, where the PI3K/Akt signalling pathway plays a vital role.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Brain-liver-communication; Chaihu-Shugan-San (CSS); Chronic unpredictable mild stress; Ly294002; PI3K/Akt signalling pathway; Perimenopausal depression

Mesh:

Substances:

Year:  2022        PMID: 35190952     DOI: 10.1007/s11064-022-03534-y

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  9 in total

1.  Ethnopharmacokinetic- and activity-guided isolation of a new antidepressive compound from fructus aurantii found in the traditional chinese medicine chaihu-shugan-san: a new approach and its application.

Authors:  Rong Fan; Xi Huang; Yang Wang; Xiao Chen; Ping Ren; Hui Ji; Ying Xie; Yingjin Zhang; Wei Huang; Xinjian Qiu; Zhaoqian Liu; Honghao Zhou; Lan Fan; Lichen Gao
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-01       Impact factor: 2.629

2.  The Role of Hippocampal Estradiol Receptor-α in a Perimenopausal Affective Disorders-Like Rat Model and Attenuating of Anxiety by Electroacupuncture.

Authors:  Xun Wang; Yongheng Huang; Shiwen Yuan; Amin Tamadon; Shulan Ma; Yi Feng
Journal:  Evid Based Complement Alternat Med       Date:  2016-12-01       Impact factor: 2.629

3.  Relationship between depression and inflammatory factors and brain-derived neurotrophic factor in patients with perimenopause syndrome.

Authors:  Li Guo; Lidong Ren; Caixia Zhang
Journal:  Exp Ther Med       Date:  2018-03-22       Impact factor: 2.447

4.  The Gut Microbiome Modulates the Changes in Liver Metabolism and in Inflammatory Processes in the Brain of Chronic Unpredictable Mild Stress Rats.

Authors:  Wei-Jie Lv; Xiao-Ling Wu; Wen-Qian Chen; Yue-Fei Li; Gui-Feng Zhang; Li-Min Chao; Jia-Hao Zhou; Ao Guo; Cui Liu; Shi-Ning Guo
Journal:  Oxid Med Cell Longev       Date:  2019-10-24       Impact factor: 6.543

5.  Chaihu-Shugan-San Decoction Modulates Intestinal Microbe Dysbiosis and Alleviates Chronic Metabolic Inflammation in NAFLD Rats via the NLRP3 Inflammasome Pathway.

Authors:  Yinji Liang; Yupei Zhang; Yuanjun Deng; Shu Liang; Yifang He; Yanning Chen; Chan Liu; Chenli Lin; Li Han; Guifang Tu; Qinhe Yang
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-11       Impact factor: 2.629

6.  Chaihu-Shugan-San Reinforces CYP3A4 Expression via Pregnane X Receptor in Depressive Treatment of Liver-Qi Stagnation Syndrome.

Authors:  Zehui He; Rong Fan; Chunhu Zhang; Tao Tang; Xu Liu; Jiekun Luo; Hanjin Cui; Yang Wang; Ruohuang Lu; Pingping Gan
Journal:  Evid Based Complement Alternat Med       Date:  2019-10-31       Impact factor: 2.629

7.  Antidepressant-Like Effects and Cognitive Enhancement of Coadministration of Chaihu Shugan San and Fluoxetine: Dependent on the BDNF-ERK-CREB Signaling Pathway in the Hippocampus and Frontal Cortex.

Authors:  Lijing Yan; Xia Xu; Zhenyu He; Sheng Wang; Linlin Zhao; Juan Qiu; Dongsheng Wang; Zhicheng Gong; Xinjian Qiu; Huiyong Huang
Journal:  Biomed Res Int       Date:  2020-02-22       Impact factor: 3.411

8.  Comparative Study on Pharmacokinetics of Four Active Compounds in Rat Plasma after Oral Administration of Raw and Wine Processed Chuanxiong Rhizoma.

Authors:  Yan Ning; Ke Pei; Gang Cao; Hao Cai; Xiao Liu; Lilong Cao; Shuosheng Zhang; Baochang Cai
Journal:  Molecules       Date:  2019-12-25       Impact factor: 4.411

9.  Autophagy Attenuation Hampers Progesterone Synthesis during the Development of Pregnant Corpus Luteum.

Authors:  Zonghao Tang; Zhenghong Zhang; Hong Zhang; Yuhua Wang; Yan Zhang; Jiuhua Zhao; Hongqin Yang; Zhengchao Wang
Journal:  Cells       Date:  2019-12-27       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.